Analyst Price Targets — ABL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 23, 2025 9:45 am | — | UBS | $11.00 | $8.50 | TheFly | Abacus Global price target raised to $11 from $9 at Piper Sandler |
| October 9, 2025 10:39 am | — | Piper Sandler | $9.00 | $5.96 | TheFly | Abacus Global price target lowered to $9 from $10 at Piper Sandler |
| October 24, 2024 8:47 am | Mike Grondahl | Northland Securities | $13.50 | $8.88 | StreetInsider | Northland Starts Abacus Life Inc. (ABL) at Outperform |
| June 26, 2024 5:20 am | Crispin Love | Piper Sandler | $12.00 | $8.65 | TheFly | Abacus Life initiated with an Overweight at Piper Sandler |
| June 24, 2024 6:53 am | Matt Howlett | B.Riley Financial | $15.00 | $8.73 | StreetInsider | Abacus Life Inc. (ABL) PT Lowered to $15 at B.Riley |
Latest News for ABL
Strata Announces Closing of Revolving Credit Facility to Support Acquisition Strategy Execution
$30 million ABL Facility will support future acquisitions and be undrawn at close; can be increased to $50 million, subject to certain conditions Owned aircraft excluded from collateral package and remain unencumbered NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), a leading provider of logistics and medical services in the organ transplant…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for ABL.
Senate Trading
No Senate trades found for ABL.
U.S. House Trading
No House trades found for ABL.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.